Publisher
Springer Berlin Heidelberg
Reference135 articles.
1. Abernathy, R. S., Halberg, F., Spink, W. W.: Studies on the mechanism of chlorpromazine protection against brucella endotoxin in mice. J. Lab. clin. Med. 49, 708 (1957).
2. Alkjaersig, N., Fletcher, A. P., Sherry, S.: Pathogenesis of the coagulation defect developing during plasma proteolytic (fibrinolytic) states. II. The significance, mechanism, and consequence of defective fibrin polymerization. J. clin. Invest. 41, 917 (1962).
3. Ambrus, C. M., Weintraub, D. H., Dunphy, D., Dowd, J. E., Pickren, J. W., Niswander, K. R., Ambrus, J. L.: Studies on hyaline membrane disease. I. The fibrinolysin system in pathogenesis and therapy. Pediatrics 32, 10–24 (1963).
4. Apitz, K.: A study of the generalized Shwartzman phenomenon. J. Immunol. 29, 255 (1935).
5. Apitz, K.: Über Profibrin. I. Die Entstehung und Bedeutung des Profibrins im Gerinnungsverlauf. Z. ges. exp. Med. 101, 552 (1937).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Use of Streptokinase;Fibrinolytics and Antifibrinolytics;1978
2. Therapeutische Probleme des Schocks bei Urosepsis;23. Tagung vom 27. bis 31. Oktober 1970 in Baden-Baden;1971